Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/1999
05/26/1999EP0917459A1 Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
05/26/1999EP0917458A1 Lyophilized thioxanthenone antimumor agents
05/26/1999EP0917457A1 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs
05/26/1999EP0917428A1 Hybrid matrix implants and explants
05/26/1999EP0836506A4 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
05/26/1999EP0804459A4 Therapeutic compound - fatty acid conjugates
05/26/1999EP0804245B1 Collagen preparation for the controlled release of active substances
05/26/1999EP0678034B1 Inducing cytotoxic t lymphocyte responses
05/26/1999CN1217791A Graphitic nanotubes in luminescence analysis
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217733A Polymer powders redispersible in aqueous solution
05/26/1999CN1217731A Improved preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using same
05/26/1999CN1217662A Water soluble paclitaxel prodrugs
05/26/1999CN1217658A Dicloroanilicnophenylacetic acid/gamma-cyclodextrin inclusion compounds
05/26/1999CN1217339A Cellulose binding domain
05/26/1999CN1217335A Method for preparing precursor medicine
05/26/1999CN1217212A Vaccine both for hepatitis A and measles and production method therefor
05/26/1999CA2254434A1 Droloxifene pharmaceutical compositions
05/25/1999US5907030 Fatty acid derivatives of sulfhydryl containing peptides and proteins; for increased absorption of theraputic compounds across mucous membranes and skin
05/25/1999US5906991 Releasing and absorption, suspension and heating
05/25/1999US5906977 Conjugate for treating inflammatory diseases
05/25/1999US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor
05/25/1999US5906922 Delivery of nucleic acids
05/25/1999US5906832 Time release agents for epileptic drugs into intestines
05/25/1999US5906831 Consists of monocaproin, a polar liquid selected from ethylene glycol, propylene glycol, ethanol, glycerol and water, a biologically active material such as protein, petide, nucleic acid, vitamine or vaccine; sustained release of a drug
05/25/1999US5906830 Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
05/25/1999US5906820 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
05/25/1999US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance
05/25/1999US5906807 Enhanced contrast for nuclear magnetic resonance
05/25/1999CA2151742C Compositions for oral delivery of active agents
05/25/1999CA2138977C Cosmetic containing phospholipids and fluorocarbon compounds
05/25/1999CA2135062C Pharmaceutical and other dosage forms
05/25/1999CA2126611C Opiod formulations having extended controlled release
05/25/1999CA2073431C Interdigitation-fusion liposomes and gels
05/20/1999WO1999024559A2 Nuclear targeting by means of streptococcal protein h
05/20/1999WO1999024490A1 Strictly alternating poly(alkylene oxide ether) copolymers
05/20/1999WO1999024475A1 Piperazine-cyclodextrin complexes
05/20/1999WO1999024474A1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers
05/20/1999WO1999024472A2 Glycosylated antibodies and antibody fragments having reactive ketone groups
05/20/1999WO1999024471A1 Opiate, cannabinoid, and estrogen receptors
05/20/1999WO1999024462A2 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999WO1999024448A2 New sophoroselipids, method for their production and use
05/20/1999WO1999024396A1 Ion binding compounds, radionuclide complexes, methods of making radionuclide complexes, methods of extracting radionucleides, and methods of delivering radionuclides to target locations
05/20/1999WO1999024391A1 Radio-opaque polymer biomaterials
05/20/1999WO1999024159A1 Encapsulate of active material in alginate matrix
05/20/1999WO1999024077A2 Compositions and methods for targeted delivery of biologically-active factors
05/20/1999WO1999024076A2 Salicylate derivatized therapeutic and diagnostic agents
05/20/1999WO1999024075A2 Affinity markers for human serum albumin
05/20/1999WO1999024074A2 Novel conjugates of opioids and endogenous carriers
05/20/1999WO1999024073A1 Pharmaceutical compositions containing cyclodextrins and taxoids
05/20/1999WO1999024072A1 Release-sustaining agent for drugs and sustained-release pharmaceutical composition
05/20/1999WO1999024071A1 Method for decreasing self-association of polypeptides
05/20/1999WO1999024070A2 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field
05/20/1999WO1999024066A2 Methods and compositions for enhancing immune response and for the production of in vitro mabs
05/20/1999WO1999024063A1 Compositions providing for increased igf-i solubility
05/20/1999WO1999024061A1 Method for producing igf-1 sustained-release formulations
05/20/1999WO1999024043A1 Viscous compositions containing carbon dioxide
05/20/1999WO1999024042A2 Stable antiandrogenic gel composition
05/20/1999WO1999024041A1 Penetration enhancing and irritation reducing systems
05/20/1999WO1999024036A1 Skin penetration enhancing components
05/20/1999WO1999024028A1 Chlorphenesin as preservative
05/20/1999WO1999024020A1 A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition
05/20/1999WO1999024017A1 Novel oral dosage form for carvedilol
05/20/1999WO1999024015A1 Buffered drug formulations for transdermal electrotransport delivery
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999008718A3 Bioresorbable compositions for implantable prostheses
05/20/1999WO1999001118A9 Antioxidant enhancement of therapy for hyperproliferative conditions
05/20/1999WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules
05/20/1999DE19750245A1 Use of anionic geminal surfactant(s) in cosmetic applications
05/20/1999CA2628053A1 Affinity markers for human serum albumin
05/20/1999CA2309955A1 Method for decreasing self-association of polypeptides
05/20/1999CA2309819A1 A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition
05/20/1999CA2309640A1 Nuclear targeting by means of bacterial proteins
05/20/1999CA2309597A1 Sustainedly releasing agents for medicines and sustainedly released medicinal compositions containing the same
05/20/1999CA2309542A1 Novel oral dosage form for carvedilol
05/20/1999CA2309320A1 Glycosylated antibodies and antibody fragments having reactive ketone groups
05/20/1999CA2309205A1 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999CA2309123A1 Stable antiandrogenic gel composition
05/20/1999CA2306465A1 Piperazine-cyclodextrin complexes
05/19/1999EP0916726A1 Attaching substances to micro-organisms
05/19/1999EP0916662A2 Ascorbylsorbate
05/19/1999EP0916348A1 Drug complexes
05/19/1999EP0916347A1 Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
05/19/1999EP0916343A1 use of alkzl phosphoric acid compounds for the treatment of psoriatic diseases
05/19/1999EP0916340A1 Suppositories
05/19/1999EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells
05/19/1999EP0915902A1 Transgenic animals expressing artificial epitope-tagged proteins
05/19/1999EP0915703A1 Combinations of an ursodeoxycholic acid compound and a nsaid for the chemopreventive protection of the colorectum
05/19/1999EP0915684A1 Material for buffered resorbable internal fixation devices and method for making same
05/19/1999EP0804456A4 Peptide nucleic acid conjugates
05/19/1999CN1216995A Amphipathic molecules as cholesterol and other lipid uptake inhibitors
05/19/1999CN1216925A Novel Dispersible lipid blends and uses therefor
05/19/1999CN1216923A Inclusion complexes of aryl-heterocyclic salts
05/19/1999CN1216919A Improvement in the taste of active pharmaceutical ingredients
05/19/1999CN1216705A Medicine for external use contg. camphor and menthanol, and prepn. method therefor
05/19/1999CN1043405C Method for prepn. of pharmaceutical compositions contg. heterocyclic amide derivatives
05/18/1999US5905092 Topical semisolid comprising polyhydric alcohol, mixture of gelling agents, antibiotic, water
05/18/1999US5905081 Topical formulations of azathioprine to treat inflammatory bowel disorders
05/18/1999US5905027 Identifying neoplastic brain tissues based on binding affinty of antibodiesto antigens of chloride channels
05/18/1999US5904937 Taste masked pharmaceutical compositions
1 ... 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 ... 1712